metoprolol succinate NDC 51655-934

NDC codes

FDA NDC Directory

Product NDC (as listed)51655-934Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51655-0934Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51655-934-26	51655093426	90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-934-26)Marketed from Jul 25, 2022
51655-934-52	51655093452	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-934-52)Marketed from Sep 16, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): metoprolol succinate
Generic name (nonproprietary): metoprolol succinate
Active ingredients: Metoprolol succinate — 25 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Northwind Health Company, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204161
Marketing start: Jul 25, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 51655-934_4bbd9310-c072-86ae-e063-6294a90a92eeSPL ID 4bbd9310-c072-86ae-e063-6294a90a92eeSPL set ID f76d782a-59fe-2093-e053-6394a90a8668RxCUI 866427UNII TH25PD4CCB
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451655093426 followed by a unit qualifier and the quantity

Package 51655-0934-26. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 1, 2026.

Indications (excerpt from the label)

Metoprolol succinate extended-release tablets are a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Angina Pectoris. ( 1.2 ) Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure. ( 1.3 ) 1.1 Hypertension Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myoca…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 204161

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204161
Product	Strength	Form · route	Labeler	Product NDC
metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Film coated, Extended releaseOral	Northwind Health Company, LLC	51655-519
metoprolol succinate	Metoprolol succinate 25 mg/1	Tablet, Film coated, Extended releaseOral	Proficient Rx LP	71205-368
metoprolol succinate	Metoprolol succinate 200 mg/1	Tablet, Film coated, Extended releaseOral	Actavis Pharma, Inc.	45963-678
metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Film coated, Extended releaseOral	Actavis Pharma, Inc.	45963-676
metoprolol succinate	Metoprolol succinate 100 mg/1	Tablet, Film coated, Extended releaseOral	Actavis Pharma, Inc.	45963-677
metoprolol succinate	Metoprolol succinate 25 mg/1	Tablet, Film coated, Extended releaseOral	Actavis Pharma, Inc.	45963-709
metoprolol succinate	Metoprolol succinate 100 mg/1	Tablet, Film coated, Extended releaseOral	Northwind Health Company, LLC	51655-193
metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Film coated, Extended releaseOral	Proficient Rx LP	71205-800
metoprolol succinate	Metoprolol succinate 100 mg/1	Tablet, Film coated, Extended releaseOral	Proficient Rx LP	71205-801